Advances in dissolution testing equipment are helping to meet user demands to a certain degree; however, more innovation in the space may be necessary for novel therapies, such as biologics.
Advances in dissolution testing technology have been one of the biggest breakthroughs in solid dosage form testing over the last decade. The full version of this analytical technologies feature can be ...
Developing a pharmaceutical product involves much more than identifying an effective active ingredient. Researchers must also understand how a medicine behaves after it enters the body, including how ...
The British Pharmacopoeia on Monday released its response to its consultation on dissolution testing and announced its plans to update its approach within its product monographs. The British ...
FDA Chlorthalidone dissolution testing recall: Over 25,000 bottles of blood pressure medication have been recalled for improper dissolution. Reports claim that India based Inventia Healthcare Limited ...
In the manufacture of solid dosage forms, the rate at which the active pharmaceutical ingredient (API) is dissolved into solvents simulating the digestive tract fluids is determined with dissolution ...
What is dissolution testing and why is important in drug development, formulation and testing? For this Teach Me in 10 episode, we're joined by Lorraine Kay from Agilent Technologies who gives us a ...
The dissolution profile of inhaled drugs underpins therapeutic efficacy and is an area of increasing regulatory scrutiny, particularly for the demonstration of bioequivalence in a generic. The new ...
The US Food and Drug Administration (FDA) on Wednesday released final guidance for sponsors on when a standard release test and criteria may be used in lieu of extensive method development and ...
Thousands of bottles of a popular blood pressure medication are being recalled over concerns about effectiveness. Inventia Healthcare Limited is voluntarily recalling 13,567 bottles of Chlorthalidone ...
What is dissolution testing and why is important in drug development, formulation and testing? For this Teach Me in 10 episode, we're joined by Lorraine Kay from Agilent Technologies who gives us a ...